Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Wockhardt in trouble with USFDA
Description
According to a letter from the FDA to Wockhardt chairman Habil Khorakiwala, there is a larger problem at the drug-maker than just manufacturing compliance issues. Mint's CH Unnikrishnan shares the details with Zahra Khan.
More from User
06:52
Jet Airways crisis: Who is to blame, lending banks or promoter Naresh Goyal?
Mint
01:38
What to expect from Reliance Q4 earnings?
Mint
29:58
Zia Mody on adversarial deal making, fear of missing out in private equity
Mint
19:20
Apex Court squashes RBI's Feb 12 Circular on Stressed Assets Resolution : A Decode
Mint
12:50
Marico Founder Harsh Mariwala on how Indian start-ups can scale up & thrive
Mint
23:10
'Hostile' takeovers: L&T-Mindtree saga signals new era in Indian M&A deals?
Mint
Related Videos
04:42
From the newsroom: Fortune smiles on Wockhardt again
Mint
03:33
FDA charges data integrity issues in Wockhardt factories
Mint
01:53
Air India's pilot trouble
Mint
01:08
Fuelling trouble
Mint
01:32
What’s the trouble with the Chinese market?
Mint
01:52
Matunga garden flyover faces teething troubles
Mint